Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
---|---|---|---|---|---|
AK1-H5283 | Human | Human Akt1 Protein, His,Strep II Tag |
|
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Hu-7691 | Hu-7691 | Phase 1 Clinical | Zhejiang University | Neoplasms | Details |
Oxysterols (Intsel Chimos) | Clinical | Centre National De La Recherche Scientifique (Cnrs) | Glioma | Details | |
NTQ-1062 | NTQ1062; NTQ-1062 | Phase 1 Clinical | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | Solid tumours | Details |
MSC-2363318A | M-2698; MSC-2363318A | Merck Serono | Details | ||
BAY-1125976 | BAY-1125976 | Bayer AG | Details | ||
TAS-117 | TAS-117 | Phase 2 Clinical | Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd | Solid tumours | Details |
HZB-0071 | HZB-0071 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd | Neoplasms | Details |
Honokiol | HU-002; JRF-101 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Non-alcoholic Fatty Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung | Details |
Triciribine Phosphate | NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 | Phase 2 Clinical | National Cancer Institute | Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms | Details |
Selumetinib sulfate/MK-2206 | Phase 2 Clinical | Astrazeneca Plc, Merck & Co Inc | Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung | Details | |
Uprosertib/Trametinib Dimethyl Sulfoxide | Phase 2 Clinical | Novartis Pharma Ag | Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms | Details | |
Miransertib | MK-7075; ARQ-092 | Phase 2 Clinical | Arqule Inc | Ovarian Neoplasms; Solid tumours; Proteus Infections; Neoplasms; Proteus Syndrome; Lymphoma; Endometrial Neoplasms | Details |
Capivasertib | AZD-5363 | Phase 3 Clinical | Astrazeneca Pharmaceutical Co Ltd | Glioma; Prostatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Thyroid Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Esophageal adenocarcinoma; Lymphoma; Breast Neoplasms; Fallopian Tube Neoplasms; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Carcinoma, Squamous Cell; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Triple Negative Breast Neoplasms; Solid tumours; Liver Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Neoplasms; Hematologic Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Skin Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant | Details |
RX-0301 | RX-0301; WGI-0301; RX-0201改良型; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N | Phase 1 Clinical | Rexahn Pharmaceuticals Inc | Liver Neoplasms; Solid tumours; Neoplasms | Details |
Afuresertib | ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 | Phase 3 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag | Histiocytosis, Langerhans-Cell; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Peritoneal Neoplasms; Solid tumours; Breast Neoplasms; Multiple Myeloma; Neoplasms; Triple Negative Breast Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms | Details |
Ipatasertib Dihydrochloride | RG-7440; GCD-0068; GDC-0068; RO-5532961 | Phase 3 Clinical | Array Biopharma, F. Hoffmann-La Roche Ltd | Hepatic Insufficiency; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Carcinoma, Endometrioid; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Uterine Neoplasms; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Oropharyngeal Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Glioblastoma; Hypopharyngeal Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Cystadenocarcinoma, Serous; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasm, Residual; Head and Neck Neoplasms; Solid tumours | Details |
MK-2206 | MK2206; MK-2206; BIND-2206; NSC-749607 | Phase 2 Clinical | Merck Sharp & Dohme Corp | Peritoneal Neoplasms; Waldenstrom Macroglobulinemia; Neoplasms, Gonadal Tissue; Carcinoma, Squamous Cell; Glioma; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Thymoma; Gallbladder Neoplasms; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Adenocarcinoma, Bronchiolo-Alveolar; Sezary Syndrome; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Leukemia, Myeloid, Chronic-Phase; Colorectal Neoplasms; Bile Duct Neoplasms; Nasopharyngeal Carcinoma; Carcinoma, Adenosquamous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Monocytic, Acute; Breast Neoplasms, Male; Mycosis Fungoides; Carcinoma, Hepatocellular; Leukemia, T-Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Prolymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Lymphoma, Follicular; Lymphoma; Leukemia, Myelomonocytic, Juvenile; Adenocarcinoma, Mucinous; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Intraocula | Details |
Iopofosine I-131 | HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404; 131I-NM-404; CLR-131; (131)I-CLR1404; NM404 | Phase 2 Clinical | University Of Michigan | Sarcoma, Ewing; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Neuroblastoma; Lymphoma, Mantle-Cell; Osteosarcoma; Head and Neck Neoplasms; Brain Neoplasms; Multiple Myeloma; Central Nervous System Neoplasms; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Rhabdomyosarcoma; Lymphoma, B-Cell, Marginal Zone; Solid tumours | Details |
Uprosertib | GSK-795; GSK-2141795; GSK-2141795C; UPB-795 | Phase 2 Clinical | Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute | Solid tumours; Hematologic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Multiple Myeloma; Breast Neoplasms; Lymphoma; Endometrial Neoplasms; Uterine Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Uterine Cervical Neoplasms; Adenocarcinoma | Details |
TIC-10 | ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 | Phase 3 Clinical | Oncoceutics Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Adenomatous Polyps; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Glioma; Colorectal Neoplasms; Gliosarcoma; Diffuse Intrinsic Pontine Glioma; Solid tumours; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Central Nervous System Neoplasms; Thalamic Diseases; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Glioblastoma; Adenomatous Polyposis Coli | Details |
This web search service is supported by Google Inc.